IL69763A - Preparation of 25-hydroxyvitamin d2,and its 24 epimer and certain novel analogs and derivatives thereof - Google Patents

Preparation of 25-hydroxyvitamin d2,and its 24 epimer and certain novel analogs and derivatives thereof

Info

Publication number
IL69763A
IL69763A IL69763A IL6976383A IL69763A IL 69763 A IL69763 A IL 69763A IL 69763 A IL69763 A IL 69763A IL 6976383 A IL6976383 A IL 6976383A IL 69763 A IL69763 A IL 69763A
Authority
IL
Israel
Prior art keywords
hydroxyvitamin
epimer
derivatives
preparation
certain novel
Prior art date
Application number
IL69763A
Other languages
English (en)
Other versions
IL69763A0 (en
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Priority to IL8075983A priority Critical patent/IL80759A/xx
Publication of IL69763A0 publication Critical patent/IL69763A0/xx
Priority to IL80759A priority patent/IL80759A0/xx
Publication of IL69763A publication Critical patent/IL69763A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL69763A 1982-09-20 1983-09-18 Preparation of 25-hydroxyvitamin d2,and its 24 epimer and certain novel analogs and derivatives thereof IL69763A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL8075983A IL80759A (en) 1982-09-20 1983-09-18 5,7-diene steroids useful as intermediates in the synthesis of 2k-hydroxyvitamin d2 and analogs thereof
IL80759A IL80759A0 (en) 1982-09-20 1986-11-25 5,7-diene steroids useful as intermediates in the synthesis of 25-hydroxy-vitamin d2 and analogs thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/420,191 US4448721A (en) 1982-09-20 1982-09-20 Hydroxyvitamin D2 compounds and process for preparing same

Publications (2)

Publication Number Publication Date
IL69763A0 IL69763A0 (en) 1983-12-30
IL69763A true IL69763A (en) 1987-01-30

Family

ID=23665448

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69763A IL69763A (en) 1982-09-20 1983-09-18 Preparation of 25-hydroxyvitamin d2,and its 24 epimer and certain novel analogs and derivatives thereof

Country Status (11)

Country Link
US (1) US4448721A (xx)
EP (1) EP0119251A1 (xx)
JP (6) JPS59501746A (xx)
CA (1) CA1283422C (xx)
CH (1) CH671222A5 (xx)
DE (2) DE3390212T1 (xx)
FR (3) FR2540869B1 (xx)
GB (2) GB2127023B (xx)
IE (1) IE56174B1 (xx)
IL (1) IL69763A (xx)
WO (1) WO1984001155A1 (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036061A (en) * 1983-05-09 1991-07-30 Deluca Hector F Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds
US4505906A (en) * 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US5120722A (en) * 1984-02-08 1992-06-09 Hoffmann-La Roche Inc. Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
DE3590488T (de) * 1984-10-04 1986-10-09 Wisconsin Alumni Research Foundation, Madison, Wis. Vitamin D-Derivate und Verfahren zu deren Herstellung
US4857518A (en) * 1984-10-04 1989-08-15 Wisconsin Alumni Research Foundation Hydroxylated 24-homo-vitamin D derivatives and methods for preparing same
US5225579A (en) * 1988-03-16 1993-07-06 Hoxan Corporation Method of manufacturing vitamin D2, Vitamin D3, activated type vitamin D2, activated type vitamin D3, and their derivatives
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
IN171426B (xx) * 1990-02-14 1992-10-10 Wisconsin Alumni Res Found
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
WO1992012165A1 (en) * 1991-01-08 1992-07-23 Lunar Corporation METHODS FOR PREPARATION AND USE OF 1α,24-DIHYDROXY VITAMIN D¿2?
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
DE69318142T2 (de) * 1992-01-29 1998-09-17 Bone Care Int Inc 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4
TW267161B (xx) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
CA2460911C (en) * 2001-10-01 2011-08-30 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US7947682B2 (en) * 2004-12-29 2011-05-24 University Of Southern California Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents
CA2882048C (en) 2006-02-03 2020-03-24 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
WO2007120972A2 (en) * 2006-02-10 2007-10-25 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) * 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
DK3357496T3 (da) 2006-06-21 2020-05-11 Opko Ireland Global Holdings Ltd Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel
ES2956794T3 (es) 2007-04-25 2023-12-28 Eirgen Pharma Ltd Liberación controlada de 25-hidroxivitamina D
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
US8058259B2 (en) * 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
EP2281058B1 (en) 2008-04-02 2016-06-29 Opko Ireland Global Holdings, Ltd. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
CN102131773B (zh) * 2008-07-22 2014-09-24 Azad药物成分股份公司 生产帕立骨化醇的方法
CA2981549A1 (en) * 2009-01-27 2010-08-05 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
SG10201404883YA (en) 2009-08-14 2014-10-30 Berg Llc Vitamin d3 and analogs thereof for treating alopecia
EP3636280A1 (en) 2010-03-29 2020-04-15 Opko Ireland Global Holdings, Ltd. Methods and compositions for reducing parathyroid levels
CA2698160C (en) * 2010-03-30 2017-07-25 Alphora Research Inc. Stabilized doxercalciferol and process for manufacturing the same
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2014274099A1 (en) 2013-05-29 2015-12-24 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin D
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법
CN115947678B (zh) * 2023-03-10 2024-01-16 成都诺森医学检验有限公司 稳定同位素2h（d）标记25-羟基维生素d2的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL150682B (nl) * 1968-07-01 1976-09-15 Wisconsin Alumni Res Found Werkwijze ter bereiding van een farmacologisch werkzaam preparaat, dat een vitamine d-derivaat bevat, alsmede gevormde voedingsmiddelen.
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US4105660A (en) * 1977-06-29 1978-08-08 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5,7-dien-25-one
US4145346A (en) * 1977-10-03 1979-03-20 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5-ene-25-one and intermediates thereof
US4229358A (en) * 1978-07-26 1980-10-21 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4265822A (en) * 1979-09-10 1981-05-05 Wisconsin Alumni Research Foundation Process for preparing 1-hydroxylated vitamin D compounds from 5,6-trans-vitamin D compounds
DE3048698A1 (de) * 1980-12-23 1982-07-15 Wisconsin Alumni Research Foundation, 53707 Madison, Wis. Verfahren zur herstellung einer 1(alpha)-hydroxylierten vitamin-d-verbindung, ausgehend von einer 5,6-trans-vitamin-d-verbindung

Also Published As

Publication number Publication date
JPH0518840B2 (xx) 1993-03-15
CA1283422C (en) 1991-04-23
FR2555172B1 (fr) 1987-08-07
FR2555172A1 (fr) 1985-05-24
JPH02209888A (ja) 1990-08-21
IL69763A0 (en) 1983-12-30
IE832203L (en) 1984-03-20
FR2555173A1 (fr) 1985-05-24
GB2127023B (en) 1987-07-08
GB8325131D0 (en) 1983-10-19
JPH02209864A (ja) 1990-08-21
US4448721A (en) 1984-05-15
JPH0610187B2 (ja) 1994-02-09
JPS59501746A (ja) 1984-10-18
FR2540869A1 (fr) 1984-08-17
JPH0518839B2 (xx) 1993-03-15
JPH02209862A (ja) 1990-08-21
WO1984001155A1 (en) 1984-03-29
DE3390212C2 (xx) 1991-10-31
JPH0443916B2 (xx) 1992-07-20
JPH02209863A (ja) 1990-08-21
DE3390212T1 (de) 1984-11-29
FR2555173B1 (fr) 1989-04-07
GB2127023A (en) 1984-04-04
GB2142922B (en) 1986-08-28
JPH0434540B2 (xx) 1992-06-08
DE3348322C2 (xx) 1991-07-25
JPH02209887A (ja) 1990-08-21
CH671222A5 (xx) 1989-08-15
FR2540869B1 (fr) 1988-04-15
IE56174B1 (en) 1991-05-08
GB8417477D0 (en) 1984-08-15
JPH0435458B2 (xx) 1992-06-11
EP0119251A1 (en) 1984-09-26
GB2142922A (en) 1985-01-30

Similar Documents

Publication Publication Date Title
IL69763A (en) Preparation of 25-hydroxyvitamin d2,and its 24 epimer and certain novel analogs and derivatives thereof
DE3372476D1 (en) Preparation of p-nitrosodiphenylamine
GB2159055B (en) Pharmaceutical compositions of 3,7,11,15-tetra-methylhexadec-1-en-3-ol
IL68537A (en) Preparation of 26,26,26,27,27,27,-hexafluoro-1,25-dihydroxy-cholesterol
PT81502A (en) Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same
DE3367931D1 (en) Preparation of 1,4-diketopyrrolo-(3,4-c)-pyrroles
PT77694A (en) Process for the preparation of mevalono lactone analogs and their derivatives and pharmaceutical compositions containing them
DE3377212D1 (en) New substituted derivatives of 2,5-diamino 1,4-diazole, preparation methods thereof and pharmaceutical compositions containing them
IL60905A0 (en) Preparation of 1-hydroxylated vitamin d compounds from 5,6-trans-vitamin d compounds
IL69996A0 (en) Substituted bis-phenoxy compounds and their thio analogs and pharmaceutical compositions containing them
GB8300598D0 (en) Preparation of 3,3'/3,4' diaminobenzophenones
IL69322A (en) Preparation of substituted thiadiazolyloxyacetamides
IL74264A (en) Preparation of calciferol derivatives,certain such novel compounds and pharmaceutical compositions containing them
GB8317345D0 (en) Preparation of arylethylamines
GB8321666D0 (en) Preparation of materials
ZA83923B (en) Use of cholecalciferol derivatives
GB8322800D0 (en) Preparation of 1,2,4,5-tetraalkylbenzenes
IL69848A0 (en) 15-cycloaliphatic derivatives of 11,14-didehydrocarboprostacyclins,their preparation and pharmaceutical compositions containing them
GB2120656B (en) Preparation of thio-bis-phenols
DE3360784D1 (en) Preparation of nitro-olefins
IL69385A0 (en) Preparation of 1-azolyl-3,3-dimethyl-1-phenoxybutan-2-ols
IL65464A0 (en) Haloalkylthio-1,3-dihydro 2,4-dioxo-quinazolines,a method of their preparation and microbicidal compositions containing them
GB8300977D0 (en) Preparation of substituted chloroacentanilides
AU553454B2 (en) Preparation of 3,3:-diaminodiphenyl sulfones
AU7777681A (en) 3-amino-2-alkenylimidates, 5 analogs and preparation of 2-aminopyrimidines

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired